Almitas Capital’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-55,000
Closed -$779K – 117
2025
Q4
$779K Buy
+55,000
New +$796K 0.17% 66
2024
Q3
– Sell
-44,339
Closed -$728K – 69
2024
Q2
$728K Buy
+44,339
New +$713K 0.3% 56
2023
Q1
– Sell
-925,786
Closed -$12.8M – 101
2022
Q4
$12.8M Buy
925,786
+522,673
+130% +$7.38M 5.92% 4
2022
Q3
$5.49M Buy
403,113
+390,296
+3,045% +$5.8M 4.1% 6
2022
Q2
$188K Buy
+12,817
New +$198K 0.1% 71

Other funds holding BCAT

Almitas Capital's BCAT Position: Q1 2026 in Review

Almitas Capital sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 55,000 shares — an estimated $779K sold.

Almitas Capital first reported a position in BCAT in Q2 2022 and held it in 5 quarters. The position peaked at $12.8M in Q4 2022. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Almitas Capital reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
  • Almitas Capital sold 55,000 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $779K.
  • Almitas Capital first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 5 quarters.
  • Almitas Capital's BlackRock Capital Allocation Term Trust position peaked at $12.8M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.